Sarepta Therapeutics

Sarepta develops and commercializes ribonucleic acid targeted therapeutics for the treatment of neuromuscular diseases.

Business Model:

Revenue: $876M

Employees: 501-1,000

Detailed Sarepta Therapeutics Information

Geographic Data

Sarepta Therapeutics headquarters map

Address: 215 First Street

City: Cambridge

State: MA

Zip: 02142

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$500M

Raised Total:

$1B

Metrics

1,444,299Website Global Rank

18,464Website Monthly Traffic

Twitter Followers

Description

Sarepta develops and commercializes ribonucleic acid targeted therapeutics for the treatment of neuromuscular diseases.

Contact Phone:
+16172744000

Contact Email:

Sarepta Therapeutics went public on 6/4/1997 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
6/4/1997

IPO Valuation:
$96M

Ticker Symbol:
SRPT

IPO Price:
$9/share

Amount Raised:
$18M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
5/2018 Myonexus Therapeutics Corporate Round 60M
8/2018 Lacerta Therapeutics Equity 30M
10/2020 AavantiBio Series A 0
3/2021 StrideBio Series B 0
3/2021 StrideBio Series B 0
10/2020 AavantiBio Series A 0
8/2018 Lacerta Therapeutics Venture Round 0
5/2018 Myonexus Therapeutics Corporate Round 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Announced Date Transaction Number of Investors Money Raised Lead Investors
6/2015 Post-IPO Debt $40M
7/2017 Post-IPO Debt 1 $100M MidCap Financial
MidCap Financial
MidCap Financial
MidCap Financial
9/2022 Post-IPO Equity 1 $6M Michael Andrew Chambers
Michael Andrew Chambers
11/2019 Post-IPO Equity $30.5M
9/2022 Post-IPO Debt $979.4M
7/2017 Post-IPO Debt $60M MidCap Financial
10/2021 Post-IPO Equity $500M
12/2019 Post-IPO Debt 1 $250M Pharmakon Advisors
Pharmakon Advisors
Pharmakon Advisors
Pharmakon Advisors
10/2018 Post-IPO Equity $90M
2/2020 Post-IPO Equity $0 Roche Financial
Roche Financial
2/2020 Post-IPO Equity 1 $400M Roche Financial
Announced Date Name Price
2/2019 Myonexus Therapeutics
7/2014 Eisai
3/2008 Ercole Biotech

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research